Back to Results
First PageMeta Content
Orphan drugs / Alcohols / Pyrimidines / Organochlorides / Health / Dasatinib / Pulmonary hypertension / Hypertension / Health care / Chemistry / Organic chemistry / Bristol-Myers Squibb


31-RUG-2A11 !5132 ffis,E DEPARTMENT OF HEALTH
Add to Reading List

Document Date: 2014-02-19 00:52:14

Open Document

File Size: 559,35 KB

Share Result on Facebook

City

tS Kowloon / /

Company

Squibb / Bristol-Myers Squibb Pharma / /

Country

Canada / /

Currency

EUR / /

/

/

IndustryTerm

healthcare professionals / dasatinib-containing products / /

MedicalCondition

dyspnea / serious pulmonary hypertension / pulmonary arterial hypertension / oardiopulmonary disease / serious pulmonary arterial hypertension / /

MedicalTreatment

heart catheterization / /

Organization

Dept of Health / DEPARTMENT OF HEALTH PHARMAGEUTICALS REGISTRATION SECTION N&8ftfr 6i$iuftt / Department of Health / Adverse Drug Reaotion Monitoring Unit / Pharmaceutical Service / Raynrond LIANG President Hong Kong Academy of Medioine / /

/

Position

gov. hk / Governor / /

Product

SPRYCEL / /

URL

http /

SocialTag